BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

632 related articles for article (PubMed ID: 16627735)

  • 1. Emergence of drug-resistant influenza virus: population dynamical considerations.
    Regoes RR; Bonhoeffer S
    Science; 2006 Apr; 312(5772):389-91. PubMed ID: 16627735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antivirals and influenza: frequency of resistance.
    Monto AS
    Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S110-2. PubMed ID: 18820569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Resistance in influenza viruses].
    Hungnes O; Dudman SG
    Tidsskr Nor Laegeforen; 2008 Nov; 128(22):2601-6. PubMed ID: 19023375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic.
    Ward P; Small I; Smith J; Suter P; Dutkowski R
    J Antimicrob Chemother; 2005 Feb; 55 Suppl 1():i5-i21. PubMed ID: 15709056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral management of seasonal and pandemic influenza.
    Hayden FG; Pavia AT
    J Infect Dis; 2006 Nov; 194 Suppl 2():S119-26. PubMed ID: 17163384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations of neuraminidase implicated in neuraminidase inhibitors resistance.
    Ferraris O; Lina B
    J Clin Virol; 2008 Jan; 41(1):13-9. PubMed ID: 18055254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of neuraminidase inhibitors for the treatment of influenza A virus infections].
    Ferraris O; Escuret V; Bouscambert-Duchamp M; Lina B; Morfin F
    Pathol Biol (Paris); 2010 Apr; 58(2):e69-78. PubMed ID: 20303677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuraminidase inhibitor resistance in influenza viruses and laboratory testing methods.
    Nguyen HT; Fry AM; Gubareva LV
    Antivir Ther; 2012; 17(1 Pt B):159-73. PubMed ID: 22311680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral treatment and prophylaxis of influenza in primary care: German recommendations.
    Wutzler P; Kossow KD; Lode H; Ruf BR; Scholz H; Vogel GE;
    J Clin Virol; 2004 Oct; 31(2):84-91. PubMed ID: 15364262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir.
    Gubareva LV; Kaiser L; Matrosovich MN; Soo-Hoo Y; Hayden FG
    J Infect Dis; 2001 Feb; 183(4):523-31. PubMed ID: 11170976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influenza viruses resistant to the antiviral drug oseltamivir: transmission studies in ferrets.
    Herlocher ML; Truscon R; Elias S; Yen HL; Roberts NA; Ohmit SE; Monto AS
    J Infect Dis; 2004 Nov; 190(9):1627-30. PubMed ID: 15478068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perspectives on antiviral use during pandemic influenza.
    Hayden FG
    Philos Trans R Soc Lond B Biol Sci; 2001 Dec; 356(1416):1877-84. PubMed ID: 11779387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling the effects of drug resistant influenza virus in a pandemic.
    Brockmann SO; Schwehm M; Duerr HP; Witschi M; Koch D; Vidondo B; Eichner M
    Virol J; 2008 Oct; 5():133. PubMed ID: 18973656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experience with oseltamivir in the control of a nursing home influenza B outbreak.
    Parker R; Loewen N; Skowronski D
    Can Commun Dis Rep; 2001 Mar; 27(5):37-40. PubMed ID: 11260987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Oseltamivir resistant influenza in children].
    Schlegel A
    Med Monatsschr Pharm; 2005 Oct; 28(10):363-4. PubMed ID: 16245454
    [No Abstract]   [Full Text] [Related]  

  • 16. Increased adamantane resistance in influenza A(H3) viruses in Australia and neighbouring countries in 2005.
    Barr IG; Hurt AC; Iannello P; Tomasov C; Deed N; Komadina N
    Antiviral Res; 2007 Feb; 73(2):112-7. PubMed ID: 16963130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence and transmission of amantadine-resistant influenza A in a nursing home.
    Schilling M; Gravenstein S; Drinka P; Cox N; Krause P; Povinelli L; Shult P
    J Am Geriatr Soc; 2004 Dec; 52(12):2069-73. PubMed ID: 15571544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of antiviral agents and other measures in an influenza pandemic.
    Groeneveld K; van der Noordaa J
    Neth J Med; 2005 Oct; 63(9):339-43. PubMed ID: 16244380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis--North Carolina, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Sep; 58(35):969-72. PubMed ID: 19745803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The threat of an avian influenza pandemic.
    Monto AS
    N Engl J Med; 2005 Jan; 352(4):323-5. PubMed ID: 15668220
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 32.